Overview

Resveratrol for Pain Due to Endometriosis

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
0
Participant gender:
Female
Summary
This study aims to verify whether the use of 40 mg of resveratrol per day associated with monophasic contraceptive pill (levonorgestrel 0.15mg/ethinyl estradiol 0.03mg) reduces pelvic pain at the end of 2 months of treatment, compared to the use of the pill with placebo.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Treatments:
Ethinyl Estradiol
Resveratrol
Criteria
Inclusion Criteria:

- Endometriosis diagnosed by laparoscopy

Exclusion Criteria:

- Known allergy to resveratrol

- Use of gonadotropin or danazol in the last month